glp 1 agonists drug class GLP-1 Costs Explained: Managing Coverage Challenges GLP-1 Medications for Weight Loss:
Description
doi: 10.1038/385214a0

That $16.5 billion Catalent acquisition deserves a longer look

Rodriguez R, Moreno M, Lee AY, Godoy-Lugo JA, Nakano D, Nishiyama A, et al

Association between diabetes, obesity, aging, and cancer: Review of recent literature

Tissue distribution and biological functions beyond glucose metabolism: 2.2.1

Clinicians say its an administrative challenge because insurers have inconsistent coverage criteria, require time-intensive documentation, and frequently deny coverage
